Boston MA 胶质母细胞瘤临床试验
28项针对 胶质母细胞瘤的研究正在 Boston及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
招募中2/3 期
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
招募中2 期
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
招募中1/2 期
- Dana Farber Cancer Institute., Boston
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
招募中1/2 期
- Tufts Medical Center, Boston
Anti-GD2 ADC M3554 in Advanced Solid Tumors
招募中1 期
- Dana-Farber Cancer Institute, Boston
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
招募中1/2 期
- Massachusetts General Hospital - Neurology, Boston
- Dana-Farber Cancer Institute - Oncology Department, Boston
Targeted Pediatric High-Grade Glioma Therapy
招募中观察性研究
- Dana-Farber Cancer Institute, Boston
Serial MRI Scans During Radiation Therapy
招募中
- Brigham and Women Hospital, Boston
- Dana Farber Cancer Institute, Boston
Study of Olutasidenib and Temozolomide in HGG
招募中2 期
- Susan Chi, Boston
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
招募中3 期
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
招募中2 期
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
招募中2 期
- Dana Farber Cancer Institute, Boston
CARv3-TEAM-E T Cells in Glioblastoma
招募中1 期
- Massachusetts General Hospital Cancer Center, Boston
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
招募中2 期
- Dana-Farber Cancer Institute, Boston
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
招募中早期 I 期欢迎健康志愿者
- Dana-Farber Cancer Institute, Boston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
招募中2 期
- Dana-Farber Cancer Institute, Boston
G-CSF After Chemo-radiation in Patients With Glioblastoma
招募中2 期
- Massachusetts General Hospital, Boston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
招募中1/2 期
- Dana Farber Cancer Institute, Boston
CUE-102 in Recurrent Glioblastoma
招募中1 期
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
招募中1/2 期
- Dana Farber Cancer Institute, Boston
Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized Trial
招募中2 期
- Brigham and Women's Hospital, Boston
A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
招募中早期 I 期
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Massachusetts General Hospital Cancer Center, Boston
Implantable Microdevice In Primary Brain Tumors
招募中早期 I 期
- Brigham and Women's Hospital, Boston
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
招募中观察性研究
- Massachusetts General Hospital, Boston
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
招募中观察性研究
- Massachusetts General Hospital, Boston
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
招募中观察性研究
- Massachusetts General Hospital, Boston
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
招募中观察性研究
- Massachusetts General Hospital, Boston
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
招募中观察性研究
- Massachusetts General Hospital, Boston
其他城市的 胶质母细胞瘤试验
- New York City, NY30 项研究
- Houston, TX26 项研究
- Los Angeles, CA24 项研究
- Durham, NC20 项研究
- San Francisco, CA17 项研究
- Chicago, IL15 项研究
- Washington, DC15 项研究
- Columbus, OH14 项研究
- Miami, FL14 项研究
- Rochester, MN13 项研究
- Jacksonville, FL13 项研究
- Aurora, CO12 项研究
Boston的其他研究
- 乳腺癌112 项研究
- 非小细胞肺癌90 项研究
- 癌症（所有类型）85 项研究
- 转移性癌症63 项研究
- 结直肠癌63 项研究
- 肺癌62 项研究
- 卵巢癌61 项研究
- 前列腺癌59 项研究
- 抑郁症52 项研究
- 子宫内膜癌50 项研究
- 心力衰竭44 项研究
- 急性髓系白血病44 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。